Skip to main content

Table 2 Viruses identified by FA RP in patients with viral pneumonia according to empiric antibacterial therapy

From: Impact of antibacterials on subsequent resistance and clinical outcomes in adult patients with viral pneumonia: an opportunity for stewardship

 

Long course

Short course

Mixed infection

(n = 67)

(n = 28)

(n = 79)

Rhinovirus/enterovirus

15 (22.4)

6 (21.4)

19 (24.1)

Influenza

14 (20.9)

4 (14.3)

15 (19.0)

Parainfluenza

12 (17.9)

7 (25)

8 (10.1)

Respiratory syncytial virus

8 (11.9)

3 (10.7)

8 (10.1)

Human metapneumovirus

8 (11.9)

3 (10.7)

6 (7.6)

Coronavirus

6 (9.0)

2 (7.1)

8 (10.1)

Adenovirus

3 (4.5)

1 (3.6)

7 (8.9)

Multiple viruses

1 (1.5)

2 (7.1)

8 (10.1)

  1. Data expressed as number (% of total)
  2. No statistically significant differences were found between groups